Over the past three months, Penumbra Inc. [PEN] ended the trading day at $202.38 and exhibited a change of -1.39% with a 24 hour trading and reached upto the volume of 481.46K compared to its recorded trading volume of 0.99 million. PEN generated a 1 year amount change with 20.00%. Though for Principal markets a year is counted as a long time period. By having a look at the most recent performance of this stock, in the last week its amount moved by -12.36% with an amount shift of -17.30% over the last month.
On 20, November 2020, Penumbra’s Newest Generation of Indigo Aspiration System Receives FDA Clearance for Pulmonary Embolism. According to news published on Yahoo Finance, Lightning 12 and Separator 12 Now Indicated for Treatment of PE.
Analyst Birdseye View:
The most recent analyst activity for Penumbra Inc. [NYSE:PEN] stock was on September 29, 2020, when it was Initiated with a Buy rating from BTIG Research, which also raised its 12-month price target on the stock to $233. Before that, on October 07, 2020, Canaccord Genuity Recapitulated a Buy rating and elevated its amount target to $253. On September 08, 2020, BofA Securities Downgrade a Neutral rating. On March 05, 2020, Citigroup Initiated a Buy rating and increased its price target to $200. On June 13, 2019, BofA/Merrill Reiterated a Buy rating and increased its price target to $180. On May 30, 2019, JP Morgan Upgrade an Overweight rating. On May 21, 2019, William Blair Initiated an Outperform rating. BofA/Merrill elevated its amount target by recapitulating a higher weight for this stock.
In the past 52 weeks of trading, this stock has oscillated between a low of $121.80 and a peak of $277.00. Right now, according to Wall Street analyst the average 12-month amount target is $270.17. At the most recent market close, shares of Penumbra Inc. [NYSE:PEN] were valued at $202.38. According to the average price forecast, investors can expect a potential return of 0.67%.
Penumbra Inc. [NYSE:PEN] most recently reported quarterly sales of 151.08 billion, which represented growth of 8.30%. This publicly-traded organization’s revenue is $202,743 per employee, while its income is $17,947 per employee. This company’s Gross Margin is currently 63.50%, its Operating Margin is -4.90%, its Pretax Margin is +9.16, and its Net Margin is +8.85. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at 8.21, 10.67, 9.59 and 9.87 respectively.
If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 14.48 and the whole liability to whole assets at 12.36. It shows enduring liability to the whole principal at 13.02 and enduring liability to assets at 0.11 while looking for an extended time period.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 199.57 points at 1st support level, the second support level is making up to 193.89. But as of 1st resistance point, this stock is sitting at 213.44 and at 221.64 for 2nd resistance point.
Penumbra Inc. [PEN] reported its earnings at $0.06 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.08/share signifying the difference of 0.14 and 175.00% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.3 calling estimates for -$0.39/share with the difference of 0.09 depicting the surprise of 23.10%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for Penumbra Inc. [NYSE:PEN] is 5.50. Likewise, the Quick ratio is also the same, showing Cash ratio at 2.08. Now if looking for a valuation of this stock’s amount to sales ratio it’s 10.88 and it’s amount to book ratio is 11.83.
The most recent insider trade was by Pray James Robert, President, International, and it was the sale of 5000.0 shares on Nov 17. Grewal Harpreet, the Director, completed a sale of 567.0 shares on Nov 16. On Nov 13, O’Rourke Bridget, Director, completed a sale of 65.0 shares.